457 related articles for article (PubMed ID: 9659570)
1. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
McGuire WP
Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
[TBL] [Abstract][Full Text] [Related]
2. [High-dose chemotherapy with stem cell support for solid tumors in adults].
Rodenhuis S; de Vries EG
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):731-8. PubMed ID: 10347628
[TBL] [Abstract][Full Text] [Related]
3. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy for the treatment of breast and ovarian cancer.
Cagnoni PJ; Shpall EJ
Curr Opin Oncol; 1997 Mar; 9(2):122-5. PubMed ID: 9161788
[TBL] [Abstract][Full Text] [Related]
5. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].
Handberg J; Hansen SW
Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532
[TBL] [Abstract][Full Text] [Related]
6. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.
Farquhar C; Basser R; Marjoribanks J; Lethaby A
Cochrane Database Syst Rev; 2003; (1):CD003139. PubMed ID: 12535457
[TBL] [Abstract][Full Text] [Related]
7. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.
Farquhar C; Basser R; Hetrick S; Lethaby A; Marjoribanks J
Cochrane Database Syst Rev; 2003; (1):CD003142. PubMed ID: 12535458
[TBL] [Abstract][Full Text] [Related]
8. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
[TBL] [Abstract][Full Text] [Related]
9. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
Rowlings PA; Williams SF; Antman KH; Fields KK; Fay JW; Reed E; Pelz CJ; Klein JP; Sobocinski KA; Kennedy MJ; Freytes CO; McCarthy PL; Herzig RH; Stadtmauer EA; Lazarus HM; Pecora AL; Bitran JD; Wolff SN; Gale RP; Armitage JO; Vaughan WP; Spitzer G; Horowitz MM
JAMA; 1999 Oct; 282(14):1335-43. PubMed ID: 10527180
[TBL] [Abstract][Full Text] [Related]
10. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report.
Stiff PJ; Veum-Stone J; Lazarus HM; Ayash L; Edwards JR; Keating A; Klein JP; Oblon DJ; Shea TC; Thomé S; Horowitz MM
Ann Intern Med; 2000 Oct; 133(7):504-15. PubMed ID: 11015163
[TBL] [Abstract][Full Text] [Related]
12. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.
Farquhar C; Marjoribanks J; Basser R; Hetrick S; Lethaby A
Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003142. PubMed ID: 16034887
[TBL] [Abstract][Full Text] [Related]
13. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
14. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH
N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307
[TBL] [Abstract][Full Text] [Related]
15. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.
Farquhar C; Marjoribanks J; Basser R; Lethaby A
Cochrane Database Syst Rev; 2005 Jul; (3):CD003139. PubMed ID: 16034886
[TBL] [Abstract][Full Text] [Related]
16. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.
Sweetenham JW; Santini G; Qian W; Guelfi M; Schmitz N; Simnett S; Nagler A; Holte H; Kvaloy S; Bruzzi P; Goldstone AH
J Clin Oncol; 2001 Jun; 19(11):2927-36. PubMed ID: 11387366
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.
Peters WP; Dansey RD; Klein JL; Baynes RD
Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643
[TBL] [Abstract][Full Text] [Related]
18. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
19. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors].
Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V
Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806
[TBL] [Abstract][Full Text] [Related]
20. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
